Stock Research (TEVA) Teva Pharmaceutic

Teva Pharm Inds A News Headlines

FDA outlines path for lower-priced biotech drugs

BioSante: LibiGel Lives On, FDA Word On Bio-T-Gel May Come At Any Time

Hospira challenges patents on Cubist antibiotic

UPDATE 1-Cubist's antibiotic gets generic threat from Hospira

Sponsored Links:

How to trade Teva Pharm Inds A for the Long Term The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in Teva Pharm Inds A buy low and sell high every time guaranteed. Click Here To Learn More

Technical Trading Signals for Teva Pharm Inds A This software is specially designed to give precision entry and exit points on Teva Pharm Inds A, or any other stock you choose.
Click Here to learn how to take control of your trading.

Trade Teva Pharm Inds A on Earnings, Volume & Momentum! Click here to learn more New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even Teva Pharm Inds A, if they make the cut.
Click Here & Learn To Pick Winners In An Uncertain Market

Additional Links Headlines

The Investment Case For Teva Pharmaceuticals - Seeking Alpha
The Investment Case For TEVA Pharmaceuticals ... Sclerosis and it develops central nervous system (CNS) drugs. The Investment Case

Teva investing $19M in CureTech, aiding in R&D - Yahoo! Finance
TEVA investing $19M in CureTech, aiding in R&D TEVA Pharmaceuticals to invest $19 million in ... of cancer that takes hold in the body's immune system cells.TEVA ...

Teva raises investment in cell therapy co - Globes
TEVA Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) has exercised its option to make an additional investment in MultiGene Vascular Systems Ltd. (MGVS ...

StockScouter Rating System - MSN Money
The StockScouter rating system can help you quickly analyze and assess a stock’s potential for outperforming the broad market.

Teva raises investment in cell therapy co | IsraPort.org
TEVA is to invest further in MultiGene Vascular Systems, following the completion of its blocked arteries treatment clinical trial. Continue to full article

TEVA Quote ~ TEVA Charts ~ TEVA Ratings ~ TEVA Tools


Home About Us Advertise Privacy Policy Disclaimer Contact Us	Copyright © 2005 Investing Software
High Growth Stock Investing \| Position Cost Averaging \| The Market Toolbox \| Trading Master Plan TigerShark Trading \| Peter Leeds Penny Stocks \| Stock Signal Pro Review \| HotSignals Review